Craig Audet, Vice President, and Mark Gaydos, Senior Director for Sanofi-Aventis’ US Regulatory Department Marketed Products, discuss what pharmaceutical companies can do within the social media space. Recorded at Exl Pharma’s Digital Pharma Conference.
Some of Mark’s VlogViews:
“We’re going to engage in this space, we’re not going to keep ourselves outside of social media, we need to be there. And I think there will be some momentum built towards that that the FDA will have to stand up and take notice of.”
“We’ve established some internal guidelines on posting video content on video sharing sites like Youtube; and we’ve also looked at establishing conversation monitoring. So going out there, seeing what’s being said about us and our products from that perspective.”
Some of Craig’s VlogViews:
“The regulations for what you have to do for a social media site are the same as if you’re doing a print ad or a broadcast ad. It’s not (different) in how the company meets the FDA requirements.”
“I think maybe a year or two years down the road, we’re going to see companies take steps into social media and will get feedback from the FDA and others based on those steps.”
Search Terms: Sanofi-Aventis, Craig Audet, Mark Gaydos, pharmaceutical companies, social media, digital pharma, exl Pharma, FDA
Web Influencers Survey
The results of the first ever Web Influencers Survey identified differences in how websites of TV stations, radio stations, newspapers, magazines and bloggers work with PR professionals and use content.
“Web Influencers are now the mainstream media.”
Click for a Copy of the Survey
Search Terms: Web Influencers Survey, Web Influencers, Public Relations, blogs, media, mainstream media, TV stations, radio stations, newspapers, magazines, bloggers
Posted in Blogs, Commentary | 2 Comments »